Literature DB >> 34916782

Preliminary Study on Reference Interval of Serum Pepsinogen in Healthy Subjects.

Liang Zhang1, Ye Niu1, Yin-Jiang Lv1, Li-Feng Wu1, Qi-Lei Hu1, Rong Huang1, Ru-Jin Xu1.   

Abstract

OBJECTIVE: This study determined the reference interval of pepsinogen (PG) of healthy people in the local region to provide a basis for early screening of gastric cancer.
METHODS: Among the healthy people who underwent a physical examination in our hospital from January 2020 to December 2020, 2568 subjects were selected based on the relevant screening criteria. Their serum PG I and II levels and PG I:PG II ratio were determined by chemiluminescent microparticle immunoassay (CIMA), and the results were statistically analyzed. Finally, according to document CLSI-C28-A3, the PG reference interval of the local region was determined.
RESULTS: The PG I and II levels of the males in all age groups were higher than those of the females in the corresponding age groups, and the differences were statistically significant (P < 0.05). However, the differences in the PG I:PG II ratio between the genders in the different age groups were not statistically significant (P > 0.05). The PG I and II levels increased with age in both men and women, while the PG I:PG II ratio was not correlated with age in either gender.
CONCLUSION: The PG reference interval of the local region was initially determined as providing a reliable reference basis for clinical treatment.
© 2021 Zhang et al.

Entities:  

Keywords:  CLSI-C28-A3; chemiluminescent microparticle immunoassay; pepsinogen; reference interval

Year:  2021        PMID: 34916782      PMCID: PMC8668243          DOI: 10.2147/PPA.S330656

Source DB:  PubMed          Journal:  Patient Prefer Adherence        ISSN: 1177-889X            Impact factor:   2.711


  14 in total

1.  Serum pepsinogen reference intervals in apparently healthy Chinese population with latex enhanced turbidimetric immunoassay.

Authors:  Meng Huang; Ai-Guo Tang; Sa Mu; Jing-Jing Yang; Zhong-Yuan Xiang; Bo Liu; Jia-Jin Yang
Journal:  J Clin Pathol       Date:  2013-10-29       Impact factor: 3.411

2.  Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study.

Authors:  H Watabe; T Mitsushima; Y Yamaji; M Okamoto; R Wada; T Kokubo; H Doi; H Yoshida; T Kawabe; M Omata
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

3.  Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions.

Authors:  Afshin Shafaghi; Fariborz Mansour-Ghanaei; Farahnaz Joukar; Maryam Sharafkhah; Alireza Mesbah; Kurosh Askari; Siamak Geranmayeh; Alireza Mehrvarz; Fatemeh Souti; Homayoon Sokhanvar; Saba Fakhrieh; Keyvan Aminian; Mahmud Yousefi-Mashhour; Mahmud Khosh-Sorur; Javid Rasoulian
Journal:  Asian Pac J Cancer Prev       Date:  2013

4.  A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.

Authors:  Huakang Tu; Liping Sun; Xiao Dong; Yuehua Gong; Qian Xu; Jingjing Jing; Roberd M Bostick; Xifeng Wu; Yuan Yuan
Journal:  Am J Gastroenterol       Date:  2017-03-21       Impact factor: 10.864

5.  Usefulness of gastric cancer screening using the serum pepsinogen test method.

Authors:  Kazumasa Miki; Masuo Morita; Masahiko Sasajima; Reiko Hoshina; Eiko Kanda; Yoshihisa Urita
Journal:  Am J Gastroenterol       Date:  2003-04       Impact factor: 10.864

6.  Link between Serum Pepsinogen Concentrations and Upper Gastrointestinal Endoscopic Findings.

Authors:  Sang Pyo Lee; Sun Young Lee; Jeong Hwan Kim; In Kyung Sung; Hyung Seok Park; Chan Sup Shim
Journal:  J Korean Med Sci       Date:  2017-05       Impact factor: 2.153

Review 7.  Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening.

Authors:  Xian-Zhe Chen; Cheng-Zhi Huang; Wei-Xian Hu; Ying Liu; Xue-Qing Yao
Journal:  Chin Med J (Engl)       Date:  2018-05-20       Impact factor: 2.628

8.  Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations.

Authors:  Muhammad Miftahussurur; Langgeng Agung Waskito; Hafeza Aftab; Ratha-Korn Vilaichone; Phawinee Subsomwong; Iswan Abbas Nusi; Ari Fahrial Syam; Thawee Ratanachu-Ek; Dalla Doohan; Gontar Siregar; Yudith Annisa Ayu Rezkitha; Kartika Afrida Fauzia; Varocha Mahachai; Yoshio Yamaoka
Journal:  PLoS One       Date:  2020-04-09       Impact factor: 3.240

9.  Serum pepsinogen levels in different regions of China and its influencing factors: a multicenter cross-sectional study.

Authors:  Yuling Tong; Hongguang Wang; Yi Zhao; Xueqiang He; Hongwei Xu; Hong Li; Ping Shuai; Lirong Gong; Hongbo Wu; Hongzhi Xu; Yinhu Luo; Dong Wang; Shizhu Liu; Zhenya Song
Journal:  BMC Gastroenterol       Date:  2021-06-12       Impact factor: 3.067

10.  Prevalence of gastric cancer precursors in gastroscopy-screened adults by family history of gastric cancer and of cancers other than gastric.

Authors:  Rui Wu; Cheng Yang; Lin Ji; Zhi-Ning Fan; Yu-Wen Tao; Qiang Zhan
Journal:  BMC Cancer       Date:  2020-11-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.